Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

494
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
494
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
Dementia01:30

Dementia

115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
115

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Capturing Requirements for a Data Annotation Tool for Intensive Care: Experimental User-Centered Design Study.

JMIR human factors·2025
Same author

Beyond Expected Patterns in Insulin Needs of People With Type 1 Diabetes: Temporal Analysis of Automated Insulin Delivery Data.

JMIRx med·2024
Same author

Estimating Information Theoretic Measures via Multidimensional Gaussianization.

IEEE transactions on pattern analysis and machine intelligence·2024
Same author

Explainable hierarchical clustering for patient subtyping and risk prediction.

Experimental biology and medicine (Maywood, N.J.)·2023
Same author

Design and Evaluation of an Intensive Care Unit Dashboard Built in Response to the COVID-19 Pandemic: Semistructured Interview Study.

JMIR human factors·2023
Same author

Image Statistics Predict the Sensitivity of Perceptual Quality Metrics.

ArXiv·2023

Related Experiment Video

Updated: Jul 9, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K

A robust class decomposition-based approach for detecting Alzheimer's progression.

Maha M Alwuthaynani1,2, Zahraa S Abdallah1, Raul Santos-Rodriguez1

  • 1University of Bristol, Bristol BS8 1TH, UK.

Experimental Biology and Medicine (Maywood, N.J.)
|December 7, 2023
PubMed
Summary

This study introduces a novel class decomposition transfer learning (CDTL) approach for Alzheimer's disease (AD) detection using structural MRI scans. The method effectively addresses class imbalance and achieves high accuracy in predicting mild cognitive impairment to AD conversion.

Keywords:
Alzheimer’s diseaseStructural MRIclass decompositionmild cognitive impairmenttransfer learning

More Related Videos

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

177
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

Related Experiment Videos

Last Updated: Jul 9, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

177
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

Area of Science:

  • Neuroimaging
  • Artificial Intelligence
  • Medical Diagnostics

Background:

  • Computer-aided diagnosis of Alzheimer's disease (AD) using structural magnetic resonance imaging (sMRI) is advancing.
  • Training deep learning models like convolutional neural networks from scratch is hindered by extensive data and computational requirements.
  • Class imbalance in datasets can lead to poor predictive performance in machine learning models.

Purpose of the Study:

  • To propose and evaluate a class decomposition transfer learning (CDTL) approach for detecting AD from sMRI.
  • To assess the robustness of the CDTL approach across various Alzheimer's Disease Neuroimaging Initiative (ADNI) cohorts.
  • To improve the prediction of mild cognitive impairment (MCI) to AD conversion.

Main Methods:

  • Employed transfer learning by leveraging pre-trained models (VGG19, AlexNet).
  • Utilized a class decomposition technique to handle dataset irregularities and class imbalance.
  • Integrated an entropy-based method for enhanced classification.

Main Results:

  • The CDTL approach demonstrated effectiveness in detecting AD from sMRI data.
  • Comparable classification accuracy was observed across different ADNI cohorts, indicating robustness.
  • Achieved state-of-the-art performance with 91.45% accuracy in predicting MCI-to-AD conversion.

Conclusions:

  • The proposed CDTL method offers a practical and effective solution for AD detection from sMRI.
  • Transfer learning and class decomposition are valuable strategies for overcoming challenges in medical image analysis.
  • The model shows significant potential for early detection and prediction of AD progression.